Apimeds Pharmaceuticals US, Inc. (NYSE: APUS) (“Apimeds”) today announced the expansion of the Apimeds ai² Futures Lab ...
US initiative follows recent CE certification of Ciliatech’s flagship eye implant, Intercil® Uveal Spacer, novel treatment for patients with mild to moderate glaucomaDecisive move unlocks ...
Black Book’s 2026 international survey of 210 health executives highlights a regional push to replace legacy interoperability engines with open, future-proof data architectures. BARCELONA, ES / ACCESS ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback